1t5q
From Proteopedia
| Line 1: | Line 1: | ||
[[Image:1t5q.gif|left|200px]] | [[Image:1t5q.gif|left|200px]] | ||
| - | + | <!-- | |
| - | + | The line below this paragraph, containing "STRUCTURE_1t5q", creates the "Structure Box" on the page. | |
| - | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
| - | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
| - | | | + | or leave the SCENE parameter empty for the default display. |
| - | | | + | --> |
| - | + | {{STRUCTURE_1t5q| PDB=1t5q | SCENE= }} | |
| - | + | ||
| - | + | ||
| - | }} | + | |
'''Solution Structure of GIP(1-30)amide in TFE/Water''' | '''Solution Structure of GIP(1-30)amide in TFE/Water''' | ||
| Line 19: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
| - | 1T5Q is a [[Single protein]] structure | + | 1T5Q is a [[Single protein]] structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1T5Q OCA]. |
==Reference== | ==Reference== | ||
| Line 30: | Line 27: | ||
[[Category: Malthouse, J P.G.]] | [[Category: Malthouse, J P.G.]] | ||
[[Category: Parker, J C.]] | [[Category: Parker, J C.]] | ||
| - | [[Category: | + | [[Category: Diabetes]] |
| - | [[Category: | + | [[Category: Gip]] |
| - | [[Category: | + | [[Category: Helix]] |
| - | [[Category: | + | [[Category: Molecular modelling]] |
| - | [[Category: | + | [[Category: Nmr]] |
| - | [[Category: | + | [[Category: Obesity]] |
| - | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 09:33:38 2008'' | |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
Revision as of 06:33, 3 May 2008
Solution Structure of GIP(1-30)amide in TFE/Water
Overview
Glucose-dependent insulinotropic polypeptide is an incretin hormone that stimulates insulin secretion and reduces postprandial glycaemic excursions. The glucose-dependent action of GIP on pancreatic beta-cells has attracted attention towards its exploitation as a potential drug for type 2 diabetes. Use of NMR or X-ray crystallography is vital to determine the three-dimensional structure of the peptide. Therefore, to understand the basic structural requirements for the biological activity of GIP, the solution structure of the major biologically active fragment, GIP(1-30)amide, was investigated by proton NMR spectroscopy and molecular modelling. The structure is characterised by a full length alpha-helical conformation between residues F(6) and A(28). This structural information could play an important role in the design of therapeutic agents based upon GIP receptor agonists.
About this Structure
1T5Q is a Single protein structure. Full crystallographic information is available from OCA.
Reference
NMR structure of the glucose-dependent insulinotropic polypeptide fragment, GIP(1-30)amide., Alana I, Hewage CM, Malthouse JP, Parker JC, Gault VA, O'Harte FP, Biochem Biophys Res Commun. 2004 Dec 3;325(1):281-6. PMID:15522230 Page seeded by OCA on Sat May 3 09:33:38 2008
Categories: Single protein | Alana, I. | Gault, V A. | Harte, F P.M O. | Hewage, C M. | Malthouse, J P.G. | Parker, J C. | Diabetes | Gip | Helix | Molecular modelling | Nmr | Obesity
